CID 470707

Bdbm2057

Structural Information

Molecular Formula
C19H17ClN6OS
SMILES
CCN1C2=C(C=CC(=N2)Cl)N(C(=O)C3=C1N=CC(=C3)CSC4=NC=CC=N4)C
InChI
InChI=1S/C19H17ClN6OS/c1-3-26-16-13(18(27)25(2)14-5-6-15(20)24-17(14)26)9-12(10-23-16)11-28-19-21-7-4-8-22-19/h4-10H,3,11H2,1-2H3
InChIKey
RBFYUIXVWQHOIR-UHFFFAOYSA-N
Compound name
5-chloro-2-ethyl-9-methyl-13-(pyrimidin-2-ylsulfanylmethyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

412.0873 Da
Monoisotopic Mass

3.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 413.09458 197.3
[M+Na]+ 435.07652 209.8
[M-H]- 411.08002 199.4
[M+NH4]+ 430.12112 203.5
[M+K]+ 451.05046 205.4
[M+H-H2O]+ 395.08456 184.3
[M+HCOO]- 457.08550 201.2
[M+CH3COO]- 471.10115 204.9
[M+Na-2H]- 433.06197 199.7
[M]+ 412.08675 200.5
[M]- 412.08785 200.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.